BioTrinity 2020: Modelling in immuno-oncology – Physiomics

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

BioTrinity 2020: Modelling in immuno-oncology

Date

28th April 2020

Category

Presentations

Share

Physiomics Plc

The Magdalen Centre

Oxford Science Park

1 Robert Robinson Avenue

Oxford, OX4 4GA

United Kingdom

Email: info@physiomics.co.uk

Phone: +44 (0) 1865 784980

Quick Links

About
R&D Services
Resources
All News
Blog
Investors
Legal & Privacy Policy
Sitemap
Contact

Latest Tweets

CAR T-cell therapy is an exciting form of cancer #immunotherapy. It is good news to see this new innovative treatme… https://t.co/A8rVLrcutW
RT @hilseth_mistrov: "Dose individualisation in oncology using chemotherapy‐induced neutropenia"-PhD student example of using neutrophil co…

Newsletter

Receive news and updates from Physiomics. Select your interest below:

Corporate Scientific

Copyright © Physiomics Plc 2019. Physiomics® is a registered trademark of Physiomics Plc.

})(jQuery)